Reuters logo
BRIEF-Roche says FDA approves lucentis for treatment of diabetic retinopathy
February 9, 2015 / 6:11 AM / 3 years ago

BRIEF-Roche says FDA approves lucentis for treatment of diabetic retinopathy

Feb 9 (Reuters) - Roche Holding Ag

* Roche says the U.S. Food and Drug Administration has approved lucentis (ranibizumab injection) for treatment of diabetic retinopathy in people with diabetic macular edema Further company coverage: (Reporting By Zurich Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below